 | • レポートコード：D0-MOR-AP1149 • 出版社/出版日：Mordor Intelligence / 2020年4月20日 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：健康管理 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、総鉄結合能試薬の世界市場について調査・分析した資料で、総鉄結合能試薬の市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。 |
The Total Iron Binding Capacity Reagents Market is expected to register a CAGR of 5% during the forecast period. Total iron-binding capacity is used to check the iron content in the bloodstream. This is a type of blood test performed to check the blood flow and related disorders. Increasing prevalence of iron deficiency anemia leading to drive the growth of total iron-binding capacity reagents markets as these tests has been carried out to check the diseases. Iron deficiency anemia is common in women population due to menstrual cycle owing to boost the TIBC reagents market. Moreover, chemotherapy is also one of the factors for iron deficiency anemia due to reduced iron content and blood loss because of the inflammatory process associated with cancer treatment. Chemotherapy and radiotherapy often deplete iron contents which further boosts the revenue growth of the total iron-binding capacity reagents market.
Key Market Trends
Iron Deficiency Anemia Segment is Expected to Hold a Significant Market Share in the Total Iron Binding Capacity Reagents Market.
The increasing prevalence of iron deficiency anemia is promoting the growth of the total iron-binding capacity reagents market. As per the World Health Organization (WHO), anemia is a common disease affecting around 24.8% of the total population. This results in adoption of these tests for diagnosis and hence boost the segment growth of TIBC reagents market. Moreover, It is very important to maintain iron levels in the body as human body needs iron for oxygen transport. These tests are widely used to diagnose the targeted patient pool and hence drive the revenue growth of total iron-binding capacity reagent market.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major market share in the global Total Iron Binding Capacity Reagents Market due to the increasing prevalence of iron deficiency anemia in this region. The need to reduce the burden of iron deficiency anemia led to an increase in demand for its treatment, hence promotes the growth of the total iron-binding capacity reagents market. The prevalence of anemia is a substantial public health indicator and has remained a relevant health concern in the United States. Since 1990, the prevalence rate of iron deficiency anemia in US infants did not drop, making iron deficiency a significant public health problem in the United States. This increasing prevalence rate of iron deficiency anemia will drive the overall market in this region.
Competitive Landscape
Some of the companies which are currently dominating the market Randox Laboratories Ltd, Biosystems S.A., McKesson Medical-Surgical Inc., Sekisui Diagnostics, LLC, Thermo Fisher Scientific, Henry Schein, Diagnostic Systems GmbH
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Patient Pool Suffering from the Acute and Iron Deficiency
4.2.2 Increasing R & D expenditure
4.3 Market Restraints
4.3.1 Limited Product Availability and Time Consuming Nature of the TIBC assays
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Disease Type
5.1.1 Iron Deficiency Anemia
5.1.2 Iron Deficiency in Late Pregnancy
5.2 By End User
5.2.1 Diagnostic Laboratories
5.2.2 Hospitals
5.2.3 Clinics
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Randox Laboratories Ltd
6.1.2 Biosystems S.A.
6.1.3 McKesson Medical-Surgical Inc.
6.1.4 Sekisui Diagnostics, LLC
6.1.5 Thermo Fisher Scientific
6.1.6 Henry Schein
6.1.7 Diagnostic Systems GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS